QIAGEN GeneReader NGS System
05 November, 2015QIAGEN has announced the start of commercialisation activities for its GeneReader NGS System, a Sample to Insight next-generation sequencing (NGS) solution that enables laboratories to deliver actionable results. The system offers an end-to-end NGS workflow from primary sample to a final report that provides a simple way for clinical testing to take advantage of NGS technology and improve outcomes.
How to breed a better working dog
04 November, 2015University of Sydney researchers have identified and mapped the genetic traits that will improve the accuracy of breeding high-performing working dogs for Australian farmers.
IDT Alt-R CRISPR-Cas9 System
29 October, 2015IDT introduces the Alt-R CRISPR-Cas9 System, based on the naturally occurring S. pyogenes CRISPR RNA system. The product is said to improve genome editing potency due to research-optimised crRNAs (CRISPR RNA) and tracrRNAs (trans-activating crRNA).
Bad karma is causing million-dollar oil palm crop failures
15 September, 2015It seems that bad karma is the cause of massive oil palm crop failures.
Comparative genomics: a must for winemaking
17 August, 2015 by Graeme O’Neill"With the growing accessibility and affordability of genome sequencing, we are witnessing the birth of a new era in industrial microorganism strain development; comparative genomics in industrial strains is providing a richer and deeper understanding of the genetic composition and variation of these crucial microbes." Find out more at the Australasian Genomic Technologies Association annual conference in the Hunter Valley from 11-14 October.
Merck Millipore PureGenome Low Input NGS Library Construction Kit
23 June, 2015The PureGenome Low Input NGS Library Construction Kit streamlines the process of generating indexed or barcoded libraries for Illumina HiSeq sequencing from low amounts of input DNA (from 50 pg to 1 ng).
QIAGEN Clinical Insight bioinformatics platform
27 May, 2015QIAGEN has announced the launch of the QIAGEN Clinical Insight (QCI) bioinformatics content and software platform for clinical testing labs to interpret and report on genomic variants identified in next-generation sequencing (NGS).
Faster identification of resistant tuberculosis
15 May, 2015A team led by University College London (UCL) has reduced the time needed to genetically sequence the bacteria causing tuberculosis (Mycobacterium tuberculosis, M. tb) from patient samples from weeks to days.
Maize genome mapped in 34 hours
11 May, 2015Genomic analysis company NRGene has mapped the maize W22's genome in 34 hours. The milestone marks the successful mapping of five species of corn, four of which have been enabled by NRGene technology.
Human embryos genetically modified - but is it ethical?
28 April, 2015 by Lauren DavisIn a controversial case of CRISPR/Cas9 gene editing, Chinese scientists are claiming to have genetically modified human embryos for the very first time.
You weren't that smart - you just had the right epigenetic marks on your HES1 gene
27 April, 2015Research led by the University of Southampton, UK, provides evidence that epigenetic processes influence brain development enough to have an impact on a child's later ability to learn and their cognitive performance.
Thermo Fisher Scientific Oncomine Solid Tumour Fusion Transcript kit
24 March, 2015Thermo Fisher Scientific has released its CE-IVD Oncomine Solid Tumour Fusion Transcript kit for next-generation sequencing (NGS), designed to aid clinical decision-making and enable multiplexed sequencing of formalin-fixed, paraffin-embedded (FFPE) tumour samples.
ToolGen licenses CRISPR/Cas9 technology to Thermo Fisher Scientific
16 March, 2015Korean biotechnology company ToolGen will license its CRISPR/Cas9 intellectual property portfolio to Thermo Fisher Scientific. Thermo Fisher will utilise the technology to develop and market CRISPR reagent kits.
ToolGen licenses CRISPR/Cas9 technology to Thermo Fisher Scientific
16 March, 2015Korean biotechnology company ToolGen will license its CRISPR/Cas9 intellectual property portfolio to Thermo Fisher Scientific. Thermo Fisher will utilise the technology to develop and market CRISPR reagent kits.
Agilent Technologies ClearSeq Comprehensive Cancer research panel
04 March, 2015Agilent Technologies has launched the ClearSeq Comprehensive Cancer research panel, designed to improve the speed and accuracy of clinical cancer research. The product will enable researchers to rapidly and accurately identify disease-associated variants in tumour samples - information that can be vital to research in cancer treatments.
